317 related articles for article (PubMed ID: 21796729)
1. Genotype and cardiovascular phenotype correlations with TBX1 in 1,022 velo-cardio-facial/DiGeorge/22q11.2 deletion syndrome patients.
Guo T; McDonald-McGinn D; Blonska A; Shanske A; Bassett AS; Chow E; Bowser M; Sheridan M; Beemer F; Devriendt K; Swillen A; Breckpot J; Digilio MC; Marino B; Dallapiccola B; Carpenter C; Zheng X; Johnson J; Chung J; Higgins AM; Philip N; Simon TJ; Coleman K; Heine-Suner D; Rosell J; Kates W; Devoto M; Goldmuntz E; Zackai E; Wang T; Shprintzen R; Emanuel B; Morrow B;
Hum Mutat; 2011 Nov; 32(11):1278-89. PubMed ID: 21796729
[TBL] [Abstract][Full Text] [Related]
2. Overt cleft palate phenotype and TBX1 genotype correlations in velo-cardio-facial/DiGeorge/22q11.2 deletion syndrome patients.
Herman SB; Guo T; McGinn DM; Blonska A; Shanske AL; Bassett AS; Chow EW; Bowser M; Sheridan M; Beemer F; Devriendt K; Swillen A; Breckpot J; Digilio MC; Marino B; Dallapiccola B; Carpenter C; Zheng X; Johnson J; Chung J; Higgins AM; Philip N; Simon T; Coleman K; Heine-Suner D; Rosell J; Kates W; Devoto M; Zackai E; Wang T; Shprintzen R; Emanuel BS; Morrow BE;
Am J Med Genet A; 2012 Nov; 158A(11):2781-7. PubMed ID: 23034814
[TBL] [Abstract][Full Text] [Related]
3. Reduced dosage of β-catenin provides significant rescue of cardiac outflow tract anomalies in a Tbx1 conditional null mouse model of 22q11.2 deletion syndrome.
Racedo SE; Hasten E; Lin M; Devakanmalai GS; Guo T; Ozbudak EM; Cai CL; Zheng D; Morrow BE
PLoS Genet; 2017 Mar; 13(3):e1006687. PubMed ID: 28346476
[TBL] [Abstract][Full Text] [Related]
4. TBX1 is responsible for cardiovascular defects in velo-cardio-facial/DiGeorge syndrome.
Merscher S; Funke B; Epstein JA; Heyer J; Puech A; Lu MM; Xavier RJ; Demay MB; Russell RG; Factor S; Tokooya K; Jore BS; Lopez M; Pandita RK; Lia M; Carrion D; Xu H; Schorle H; Kobler JB; Scambler P; Wynshaw-Boris A; Skoultchi AI; Morrow BE; Kucherlapati R
Cell; 2001 Feb; 104(4):619-29. PubMed ID: 11239417
[TBL] [Abstract][Full Text] [Related]
5. Full spectrum of malformations in velo-cardio-facial syndrome/DiGeorge syndrome mouse models by altering Tbx1 dosage.
Liao J; Kochilas L; Nowotschin S; Arnold JS; Aggarwal VS; Epstein JA; Brown MC; Adams J; Morrow BE
Hum Mol Genet; 2004 Aug; 13(15):1577-85. PubMed ID: 15190012
[TBL] [Abstract][Full Text] [Related]
6. The 22q11 deletion: DiGeorge and velocardiofacial syndromes and the role of TBX1.
Papangeli I; Scambler P
Wiley Interdiscip Rev Dev Biol; 2013; 2(3):393-403. PubMed ID: 23799583
[TBL] [Abstract][Full Text] [Related]
7. Genetic modifiers of the physical malformations in velo-cardio-facial syndrome/DiGeorge syndrome.
Aggarwal VS; Morrow BE
Dev Disabil Res Rev; 2008; 14(1):19-25. PubMed ID: 18636633
[TBL] [Abstract][Full Text] [Related]
8. Mice overexpressing genes from the 22q11 region deleted in velo-cardio-facial syndrome/DiGeorge syndrome have middle and inner ear defects.
Funke B; Epstein JA; Kochilas LK; Lu MM; Pandita RK; Liao J; Bauerndistel R; Schüler T; Schorle H; Brown MC; Adams J; Morrow BE
Hum Mol Genet; 2001 Oct; 10(22):2549-56. PubMed ID: 11709542
[TBL] [Abstract][Full Text] [Related]
9. Phenotypic variability of atypical 22q11.2 deletions not including TBX1.
Verhagen JM; Diderich KE; Oudesluijs G; Mancini GM; Eggink AJ; Verkleij-Hagoort AC; Groenenberg IA; Willems PJ; du Plessis FA; de Man SA; Srebniak MI; van Opstal D; Hulsman LO; van Zutven LJ; Wessels MW
Am J Med Genet A; 2012 Oct; 158A(10):2412-20. PubMed ID: 22893440
[TBL] [Abstract][Full Text] [Related]
10. Detecting 22q11.2 deletion in Chinese children with conotruncal heart defects and single nucleotide polymorphisms in the haploid TBX1 locus.
Xu YJ; Wang J; Xu R; Zhao PJ; Wang XK; Sun HJ; Bao LM; Shen J; Fu QH; Li F; Sun K
BMC Med Genet; 2011 Dec; 12():169. PubMed ID: 22185286
[TBL] [Abstract][Full Text] [Related]
11. Dysregulation of TBX1 dosage in the anterior heart field results in congenital heart disease resembling the 22q11.2 duplication syndrome.
Hasten E; McDonald-McGinn DM; Crowley TB; Zackai E; Emanuel BS; Morrow BE; Racedo SE
Hum Mol Genet; 2018 Jun; 27(11):1847-1857. PubMed ID: 29509905
[TBL] [Abstract][Full Text] [Related]
12. Single nucleotide polymorphism discovery in TBX1 in individuals with and without 22q11.2 deletion syndrome.
Heike CL; Starr JR; Rieder MJ; Cunningham ML; Edwards KL; Stanaway IB; Crawford DC
Birth Defects Res A Clin Mol Teratol; 2010 Jan; 88(1):54-63. PubMed ID: 19645056
[TBL] [Abstract][Full Text] [Related]
13. Role of TBX1 in human del22q11.2 syndrome.
Yagi H; Furutani Y; Hamada H; Sasaki T; Asakawa S; Minoshima S; Ichida F; Joo K; Kimura M; Imamura S; Kamatani N; Momma K; Takao A; Nakazawa M; Shimizu N; Matsuoka R
Lancet; 2003 Oct; 362(9393):1366-73. PubMed ID: 14585638
[TBL] [Abstract][Full Text] [Related]
14. Analysis of TBX1 variation in patients with psychotic and affective disorders.
Funke BH; Lencz T; Finn CT; DeRosse P; Poznik GD; Plocik AM; Kane J; Rogus J; Malhotra AK; Kucherlapati R
Mol Med; 2007; 13(7-8):407-14. PubMed ID: 17622328
[TBL] [Abstract][Full Text] [Related]
15. Atypical deletion of 22q11.2: detection using the FISH TBX1 probe and molecular characterization with high-density SNP arrays.
Beaujard MP; Chantot S; Dubois M; Keren B; Carpentier W; Mabboux P; Whalen S; Vodovar M; Siffroi JP; Portnoï MF
Eur J Med Genet; 2009; 52(5):321-7. PubMed ID: 19467348
[TBL] [Abstract][Full Text] [Related]
16. Understanding the role of Tbx1 as a candidate gene for 22q11.2 deletion syndrome.
Gao S; Li X; Amendt BA
Curr Allergy Asthma Rep; 2013 Dec; 13(6):613-21. PubMed ID: 23996541
[TBL] [Abstract][Full Text] [Related]
17. The 22q11 deletion syndrome candidate gene Tbx1 determines thyroid size and positioning.
Fagman H; Liao J; Westerlund J; Andersson L; Morrow BE; Nilsson M
Hum Mol Genet; 2007 Feb; 16(3):276-85. PubMed ID: 17164259
[TBL] [Abstract][Full Text] [Related]
18. Microarray analysis of the Df1 mouse model of the 22q11 deletion syndrome.
Prescott K; Ivins S; Hubank M; Lindsay E; Baldini A; Scambler P
Hum Genet; 2005 May; 116(6):486-96. PubMed ID: 15778864
[TBL] [Abstract][Full Text] [Related]
19. Loss of CXCL12/CXCR4 signalling impacts several aspects of cardiovascular development but does not exacerbate Tbx1 haploinsufficiency.
Page M; Ridge L; Gold Diaz D; Tsogbayar T; Scambler PJ; Ivins S
PLoS One; 2018; 13(11):e0207251. PubMed ID: 30408103
[TBL] [Abstract][Full Text] [Related]
20. A Tbx1-Six1/Eya1-Fgf8 genetic pathway controls mammalian cardiovascular and craniofacial morphogenesis.
Guo C; Sun Y; Zhou B; Adam RM; Li X; Pu WT; Morrow BE; Moon A; Li X
J Clin Invest; 2011 Apr; 121(4):1585-95. PubMed ID: 21364285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
